Literature DB >> 10899429

Oligomerizaiton and fibril asssembly of the amyloid-beta protein.

A E Roher1, J Baudry, M O Chaney, Y M Kuo, W B Stine, M R Emmerling.   

Abstract

In this chapter, we attempt to analyze the evolution of the amyloid-beta (Abeta) molecular structure from its inception as part of the Abeta precursor protein to its release by the secretases and its extrusion from membrane into an aqueous environment. Biophysical studies suggest that the Abeta peptide sustains a series of transitions from a molecule rich in alpha-helix to a molecule in which beta-strands prevail. It is proposed that initially the extended C-termini of two opposing Abeta dimers form an antiparallel beta-sheet and that the subsequent addition of dimers generates a helical Abeta protofilament. Two or more protofilaments create a strand in which the hydrophobic core of the beta-sheets is shielded from the aqueous environment by the N-terminal polar domains of the Abeta dimers. Once the nucleation has occurred, the Abeta filament grows in length by the addition of dimers or tetramers.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10899429     DOI: 10.1016/s0925-4439(00)00030-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  21 in total

1.  Preparation and characterization of toxic Abeta aggregates for structural and functional studies in Alzheimer's disease research.

Authors:  Asad Jan; Dean M Hartley; Hilal A Lashuel
Journal:  Nat Protoc       Date:  2010-06-03       Impact factor: 13.491

2.  Effects of Abeta1-42 on the subunits of KATP expression in cultured primary rat basal forebrain neurons.

Authors:  Guozhao Ma; Qingxi Fu; Yong Zhang; Jianxin Gao; Jinjiao Jiang; Ailing Bi; Kejing Liu; Yifeng Du; Chunfu Chen; Yuanxiao Cui; Lin Lu
Journal:  Neurochem Res       Date:  2008-03-12       Impact factor: 3.996

Review 3.  On the key role played by altered protein conformation in Parkinson's disease.

Authors:  L F Agnati; E Baldelli; N Andreoli; A S Woods; V Vellani; D Marcellino; D Guidolin; K Fuxe
Journal:  J Neural Transm (Vienna)       Date:  2008-06-05       Impact factor: 3.575

Review 4.  Amyloid fibrils: abnormal protein assembly.

Authors:  Roma N Rambaran; Louise C Serpell
Journal:  Prion       Date:  2008-07-20       Impact factor: 3.931

Review 5.  Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches.

Authors:  Niyanta N Kumar; Michelle E Pizzo; Geetika Nehra; Brynna Wilken-Resman; Sam Boroumand; Robert G Thorne
Journal:  Bioconjug Chem       Date:  2018-10-24       Impact factor: 4.774

6.  Abeta peptides as one of the crucial volume transmission signals in the trophic units and their interactions with homocysteine. Physiological implications and relevance for Alzheimer's disease.

Authors:  L F Agnati; S Genedani; G Leo; A Forni; A S Woods; M Filaferro; R Franco; K Fuxe
Journal:  J Neural Transm (Vienna)       Date:  2006-09-14       Impact factor: 3.575

7.  Role of aggregation conditions in structure, stability, and toxicity of intermediates in the Abeta fibril formation pathway.

Authors:  Sungmun Lee; Erik J Fernandez; Theresa A Good
Journal:  Protein Sci       Date:  2007-02-27       Impact factor: 6.725

8.  Diazoxide reverses the enhanced expression of KATP subunits in cholinergic neurons caused by exposure to Aβ₁₋₄₂.

Authors:  Guozhao Ma; Jianxin Gao; Qingxi Fu; Liangliang Jiang; Ruixia Wang; Yong Zhang; Kejing Liu
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

Review 9.  ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function.

Authors:  Arlene M Manelli; W Blaine Stine; Linda J Van Eldik; Mary Jo LaDu
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

10.  Chemical chaperone and inhibitor discovery: potential treatments for protein conformational diseases.

Authors:  Jian-Hua Zhao; Hsuan-Liang Liu; Hsin-Yi Lin; Chih-Hung Huang; Hsu-Wei Fang; Shiao-Shing Chen; Yih Ho; Wei-Bor Tsai; Wen-Yih Chen
Journal:  Perspect Medicin Chem       Date:  2007-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.